Australian Institute of Health and Welfare.Morbidity of Vietnam veterans: multiple sclerosis and motor neuron disease in Vietnam veterans.Canberra: AIHW; 2001. Report No.: Supplementary report no. 3 cat. no. PHE 31.
2.
KurtzkeJ.F.Risk factors In amyotrophic lateral sclerosis. Adv Neurol1991; 56: 245–270.
3.
ChancellorA.M., WarlowC.P.Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry1992; 55: 1106–1115.
4.
EmeryA.E.Population frequencies of neuromuscular diseases II. Amyotrophic lateral sclerosis (motor neuron disease). Neuromuscul Disord1991; 1: 323–325.
5.
SvensonL.W., CwikV.A., MartinW.R.The prevalence of motor neuron disease in the Province of Alberta. Can J Neurol Sci1999; 26: 119–122.
6.
GunnarssonL.G., PalmR.Motor neuron disease and heavy manual labor: an epidemiologic survey of Värmland county, Sweden. Neuroepidemiology1984; 3: 195–206.
CherryN.Environmental health and social factors associated with motor neuron disease. Aust N Z J Public Health2002; 26: 574.
9.
DeanG., ElianM.Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales. J Neurol Neurosurg Psychiatry1993; 56: 633–637.
10.
World Health Organization.WHO Definition of Palliative Care.Geneva: WHO, 2005.
11.
MillerR., MitchellJ., LyonM., MooreD.Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (Cochrane Review). The Cochrane Library, Issue 4, 2003.
12.
LeighP., InnaneD., JewittK., MustfaN.Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease (Protocol for a Cochrane Review). The Cochrane Library, Issue 4, 2003.
13.
JohnstonM., EarllL., MitchellE., MorrisonV., WrightS.Communicating the diagnosis of motor neuron disease. Palliat Med1996; 10: 23–34.
14.
BirchP., FerlieE., CritznerC.Report on the Views and Expectations of People Affected by Motor Neuron Disease.Northampton, England: Motor Neuron Disease Association, August 1995.
15.
Motor Neuron Disease Association.Report of the Results of the 1998 Survey.Northampton, England: MND Association, August1998.
16.
Motor Neuron Disease Association.Report on the Results of the Questionnaire for Previous Carers of People With Motor Neuron Disease.London: MND Association, 2002.
17.
Motor Neuron Disease Association.Report on the Results of the Questionnaire for Present Carers of People With Motor Neuron Disease.London: MND Association, 2002.
18.
Motor Neuron Disease Association.Report on the Survey of Views and Experiences of People With Motor Neuron Disease.London: MND Association, 2002.
19.
CarterH., McKennaC., MacLeodR., GreenR.Health professionals’ responses to multiple sclerosis and motor neuron disease. Palliat Med1998; 12: 383–394.
20.
ParkerD., ForsterW., GlaetzerK.Palliative care of motor neuron disease.Adelaide: Flinders University of South Australia, International Institute of Hospice Studies, 2004.
21.
HicksF., CorcoranG.Should hospices offer respite admissions to patients with motor neuron disease?Palliat Med1993; 7: 145–150.
RussellJ.Motor Neuron Disease Association Care and Research Centre Programme: report of an evaluation.London: Charities Evaluation Services, June 1999.
24.
van den BergJ.P., KalmijnS., LindemanE., WokkeJ.H.J., van den BergL.H.Rehabilitation care for patients with ALS in the Netherlands. Amyotroph Lateral Scler Other Motor Neuron Disord2003; 4: 186–190.
25.
AlbertS.M., MurphyP.L., Del BeneM.L., RowlandL.P.Prospective study of palliative care in ALS: choice, timing, outcomes. J Neurol Sci1999; 169: 108–113.
26.
MillerR.G., AndersonFAJr., BradleyW.G., BrooksB.R., MitsumotoH., MunsatT.L., RingelS.P.The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology2000; 54: 53–57.
27.
LechtzinN., WienerC.M., ClawsonL., ChaudhryV., DietteG.B.Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes. Neurology2001; 56: 753–757.
28.
BorasioG.D., ShawP.J., HardimanO., LudolphA.C., Sales LuisM.L., SilaniV.Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotroph Lateral Scler Other Motor Neuron Disord2001; 2: 159–164.
29.
ZuchT., De BellisA.A nursing home case study and the resident classification instrument. Geriaction1996; 14: 4–10.
30.
DawsonS., KristjansonL.J.Mapping the journey: family carers’ perceptions of issues related to end-stage care of individuals with muscular dystrophy or motor neuron disease. J Palliat Care2003; 19: 36–42.
31.
WestS.R., HarrisB.J., WarrenA., WoodH., MontgomeryB., BelshamV.A retrospective study of patients with cancer in their terminal year. N Z Med J1986; 99: 197–200.
32.
ServeraE., PerezD., Gomez-MerinoE., MarinJ.Respiratory care units for non-Invasive mechanical ventilation in motor neuron disease. Thorax2000; 55: 345–346.
33.
GrayA.M.ALS/MND and the perspective of health economics. J Neurol Sci1998; 160: S2–S5.
34.
MitsumotoH.Caregiver assessment: summary. Amyotroph Lateral Scler Other Motor Neuron Disord2002; 3: S31–S34.
35.
KrivickasL.S., ShockleyL., MitsumotoH.Home care of patients with amyotrophic lateral sclerosis (ALS). J Neurol Sci1997; 152: S82–89.
36.
MandlerR.N., AndersonFAJr., MillerR.G., ClawsonL., CudkowiczM., Del BeneM.Group ACARES. The ALS Patient Care Database: insights into end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord2001; 2: 203–208.
ManuelC.E.Physician-assisted suicide permits dignity in dying: Oregon takes on Attorney General Ashcroft. J Leg Med2002; 23: 563–586.
39.
HardimanO., TraynorB.J., CorrB., FrostE.Models of care for motor neuron disease: setting standards. Amyotroph Lateral Scler Other Motor Neuron Disord2002; 3: 182–185.
40.
NeudertC., OliverD., WasnerM., BorasioG.D.The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol2001; 248: 612–616.
41.
Motor Neuron Disease Association of Victoria.Living With MND.Victoria, Australia: MNDA Victoria, 2002.
42.
Motor Neuron Disease Association of New Zealand.Motor Neuron Disease Information Pack.Wellington, New Zealand: MNDA NZ, 2002.
43.
MacLennanA. (ed). Motor Neuron Disease: a problem-solving approach for health professionals. 2nd edition. Wellington, New Zealand: MNDA NZ, 2003.
44.
HarrisR., AbramsW., TebbuttZ.The International Alliance of ALS/MND Associations. Amyotroph Lateral Scler Other Motor Neuron Disord2003; 4: 214–216.
45.
OliverD., BorasioG., WalshD.Palliative Care in Amyotrophic Lateral Sclerosis (motor neuron disease).Oxford, New York: Oxford University Press, 2000.
46.
OxtobyM., EikaasM.Multidisciplinary management from day one: the neuro-care approach to motor neuron disease. Palliat Med1993; 7: 31–36.
47.
YoungC.A.Building a care and research team. J Neurol Sci1998; 160: S137–S140.
48.
DownK., SinhaA., HughesR., HigginsonI., LeighN., ShawC.Building user participation to reshape services for people affected by motor neuron disease. J Interprof Care2002; 16: 289–290.
49.
GilleyJ.Intimacy and terminal care. J R Coll Gen Pract1988; 38: 121–122.
50.
MooreM.K.Dying at home: a way of maintaining control for the person with ALS/MND. Palliat Med1993; 7: 65–68.